Literature DB >> 1848084

Localization and induced expression of fusion genes in the rat lung.

T A Hazinski1, P A Ladd, C A DeMatteo.   

Abstract

Liposome-mediated gene transfer is useful for DNA transfection into cells in culture. We wondered whether this method could be used to introduce new DNA into the intact lung. Fusion genes containing either the Rous sarcoma virus (RSV) promoter or the mouse mammary tumor virus (MMTV) promoter (which contains glucocorticoid response elements) were linked to the bacterial gene chloramphenicol acetyltransferase (CAT), an enzyme not present in mammalian cells. Plasmids containing the RSV-CAT fusion gene were mixed with cationic liposomes (Lipofectin; BRL, Inc., Grand Island, NY), and single doses were instilled into the cervical trachea of anesthetized rats. Control rats received either liposomes or plasmid. After 24, 48, and 72 h, lungs were perfused free of blood, homogenized, and analyzed for CAT enzyme activity. Liver and kidney tissue were also obtained. We found that rats given either intratracheal liposomes or plasmid had no detectable CAT activity. By contrast, 24 h after instillation of lipid:DNA complexes, lung CAT expression remained elevated for the next 48 h but was barely detectable in liver or kidney. In another group of rats, MMTV-CAT:liposome complexes were instilled intratracheally and then the rats were injected with either dexamethasone or saline. We found that the dexamethasone-treated rats had a 5- to 10-fold higher level of lung CAT expression at 24 and 48 h than the saline-treated controls had; liver and kidney CAT levels were negligible in both groups. Dexamethasone treatment did not increase RSV-CAT expression, indicating that the dexamethasone effect on MMTV-CAT expression was related to the presence of the MMTV promoter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848084     DOI: 10.1165/ajrcmb/4.3.206

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

Review 1.  Immunological hurdles to lung gene therapy.

Authors:  S Ferrari; U Griesenbach; D M Geddes; E Alton
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

2.  Aerosol gene delivery in vivo.

Authors:  R Stribling; E Brunette; D Liggitt; K Gaensler; R Debs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 3.  Gene therapy vectors as drug delivery systems.

Authors:  S A Afione; C K Conrad; T R Flotte
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

4.  Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor.

Authors:  T Ferkol; C S Kaetzel; P B Davis
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

5.  Utilization of modified surfactant-associated protein B for delivery of DNA to airway cells in culture.

Authors:  J E Baatz; M D Bruno; P J Ciraolo; S W Glasser; B R Stripp; K L Smyth; T R Korfhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats.

Authors:  S P Janssens; K D Bloch; Z Nong; R D Gerard; P Zoldhelyi; D Collen
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 7.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

8.  Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis.

Authors:  Y Rojanasakul; L Y Wang; C J Malanga; J K Ma; J Liaw
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

Review 9.  Prospects for virus-based gene therapy for cystic fibrosis.

Authors:  T R Flotte
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

10.  Target specific optimization of cationic lipid-based systems for pulmonary gene therapy.

Authors:  D Deshpande; P Blezinger; R Pillai; J Duguid; B Freimark; A Rolland
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.